(E)-4,5,6,7-tetrachloro-2-(2-styrylphenyl)isoindoline-1,3-dione

ID: ALA4215604

Chembl Id: CHEMBL4215604

PubChem CID: 145974164

Max Phase: Preclinical

Molecular Formula: C22H11Cl4NO2

Molecular Weight: 463.15

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1ccccc1/C=C/c1ccccc1

Standard InChI:  InChI=1S/C22H11Cl4NO2/c23-17-15-16(18(24)20(26)19(17)25)22(29)27(21(15)28)14-9-5-4-8-13(14)11-10-12-6-2-1-3-7-12/h1-11H/b11-10+

Standard InChI Key:  JBICFNBLMNOMNL-ZHACJKMWSA-N

Alternative Forms

  1. Parent:

    ALA4215604

    ---

Associated Targets(Human)

NR1H3 Tchem LXR-alpha (2891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H2 Tchem LXR-beta (3841 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nr1h3 Oxysterols receptor LXR-alpha (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1h2 Oxysterols receptor LXR-beta (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.15Molecular Weight (Monoisotopic): 460.9544AlogP: 7.27#Rotatable Bonds: 3
Polar Surface Area: 37.38Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.33CX LogD: 7.33
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.18Np Likeness Score: -0.31

References

1. Nomura S, Endo-Umeda K, Fujii S, Makishima M, Hashimoto Y, Ishikawa M..  (2018)  Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.,  28  (4): [PMID:29398545] [10.1016/j.bmcl.2017.12.024]

Source